NK-104-CR Phase II Exploratory study

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222137

Enrollment

Registered

2013-07-08

Start date

2013-07-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypercholesterolemia

Interventions

investigational material(s) Generic name etc : NK-104-CR INN of investigational material : Therapeutic category code : 218 Agents for hyperlipidemias Dosage and Administration for Investigational mat

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with hypercholesterolemia

Exclusion criteria

Exclusion criteria: Those complicated with Type 1 diabetes mellitus or poorly controlled Type 2 diabetes mellitus Those complicated with poorly controlled hypertension Those complicated with poorly controlled thyroid disorder Those complicated with renal disorder Those complicated with muscular disorder

Design outcomes

Primary

Measure	Time frame
LDL-C percent change at 6th week of treatment Central laboratory test	—

Secondary

Measure	Time frame
Percent changes of lipid parameters at 2nd, 4th or 6th week of treatment Central laboratory test	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026